#glucagon — Public Fediverse posts

https://www.europesays.com/at/295896/ MASLD: Fettleber steigert Herztod-Risiko – neue Tests, Pflanzenstoffe und GLP-1-Optionen #Adipositas #AI #Angptl4 #ARTIFICIALINTELLIGENCE #AT #Austria #Diabetes #Diagnostik #Entzündung #Fettleber #Gesundheit #GLP1 #Glucagon #Health #Herzrisiko #Insulinresistenz #KI #KünstlicheIntelligenz #MASLD #Medikament #Mikrobiom #Österreich #Pcr #Semaglutid #Stuhltest #Zabopegdutide

Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits

A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
#NewsBeep #News #Health #Alcohol #AU #Australia #diabetes #electronichealthrecord #Glucagon #Glucagon-likePeptide-1 #Healthcare #Hospital #Obesity #Receptor #research #semaglutide #type2diabetes
https://www.newsbeep.com/au/820448/

Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits

A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
#NewsBeep #News #Health #Alcohol #AU #Australia #diabetes #electronichealthrecord #Glucagon #Glucagon-likePeptide-1 #Healthcare #Hospital #Obesity #Receptor #research #semaglutide #type2diabetes
https://www.newsbeep.com/au/820448/

https://www.europesays.com/ie/601598/ Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits #Alcohol #diabetes #Éire #ElectronicHealthRecord #Glucagon #GlucagonLikePeptide1 #Health #HealthCare #Healthcare #hospital #IE #Ireland #Obesity #Receptor #Research #semaglutide #Type2Diabetes

GLP-1 receptor agonists may increase hair loss risk

Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased…
#NewsBeep #News #Health #alopecia #AU #Australia #BodyMassIndex #diabetes #Drugs #Glucagon #Glucagon-likePeptide-1 #Hair #HairLoss #medicine #Obesity #Receptor #research #semaglutide #type2diabetes
https://www.newsbeep.com/au/817975/

GLP-1 receptor agonists may increase hair loss risk

Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased…
#NewsBeep #News #Health #alopecia #AU #Australia #BodyMassIndex #diabetes #Drugs #Glucagon #Glucagon-likePeptide-1 #Hair #HairLoss #medicine #Obesity #Receptor #research #semaglutide #type2diabetes
https://www.newsbeep.com/au/817975/

Generic semaglutide could improve diabetes treatment affordability in Canada

In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers predict that…
#Canada #Agonist #Cardiology #diabetes #globalhealth #Glucagon #Glucagon-likePeptide-1 #Glucose #Receptor #Research #Semaglutide #Therapy #type2diabetes
https://www.europesays.com/canada/139174/

Popular diabetes drugs do not alter the risk of developing a blinding eye condition

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 recepto…
#NewsBeep #News #Health #Age-RelatedMacularDegeneration #AU #Australia #Blood #bloodsugar #BloodVessel #diabetes #Drugs #eye #Glucagon #Glucagon-likePeptide-1 #Hormone #maculardegeneration #medicine #ophthalmology #Pharmaceuticals #Receptor #research #semaglutide #type2diabetes #WeightLoss
https://www.newsbeep.com/au/807016/

Popular diabetes drugs do not alter the risk of developing a blinding eye condition

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 recepto…
#NewsBeep #News #Health #Age-RelatedMacularDegeneration #AU #Australia #Blood #bloodsugar #BloodVessel #diabetes #Drugs #eye #Glucagon #Glucagon-likePeptide-1 #Hormone #maculardegeneration #medicine #ophthalmology #Pharmaceuticals #Receptor #research #semaglutide #type2diabetes #WeightLoss
https://www.newsbeep.com/au/807016/

Weight Loss Drug Update

Semaglutide - GLP1 = 15% weight loss
Tirzepatide - GLP1 + GIP = 21-25% WL
Retatrutide - GLP1 + GIP + Glucagon = 28% WL

Orforglipron (oral!) - non-peptide GLP1 = 12% WL
CagriSema - amylin combo = 23% WL

Survodutide treats fatty liver (62% improved MASH)

#Glucagon drugs (like Ret) burns energy and treats fatty liver.

Bottom line: choose the right drug based on your goals.

#Semaglutide #Tirzepatide #Retatrutide #obesity #weightloss #glp1 #gip

https://threadreaderapp.com/thread/2073392304090390683.html

Weight Loss Drug Update

Semaglutide - GLP1 = 15% weight loss
Tirzepatide - GLP1 + GIP = 21-25% WL
Retatrutide - GLP1 + GIP + Glucagon = 28% WL

Orforglipron (oral!) - non-peptide GLP1 = 12% WL
CagriSema - amylin combo = 23% WL

Survodutide treats fatty liver (62% improved MASH)

#Glucagon drugs (like Ret) burns energy and treats fatty liver.

Bottom line: choose the right drug based on your goals.

#Semaglutide #Tirzepatide #Retatrutide #obesity #weightloss #glp1 #gip

https://threadreaderapp.com/thread/2073392304090390683.html

Weight Loss Drug Update

Semaglutide - GLP1 = 15% weight loss
Tirzepatide - GLP1 + GIP = 21-25% WL
Retatrutide - GLP1 + GIP + Glucagon = 28% WL

Orforglipron (oral!) - non-peptide GLP1 = 12% WL
CagriSema - amylin combo = 23% WL

Survodutide treats fatty liver (62% improved MASH)

#Glucagon drugs (like Ret) burns energy and treats fatty liver.

Bottom line: choose the right drug based on your goals.

#Semaglutide #Tirzepatide #Retatrutide #obesity #weightloss #glp1 #gip

https://threadreaderapp.com/thread/2073392304090390683.html

Weight Loss Drug Update

Semaglutide - GLP1 = 15% weight loss
Tirzepatide - GLP1 + GIP = 21-25% WL
Retatrutide - GLP1 + GIP + Glucagon = 28% WL

Orforglipron (oral!) - non-peptide GLP1 = 12% WL
CagriSema - amylin combo = 23% WL

Survodutide treats fatty liver (62% improved MASH)

#Glucagon drugs (like Ret) burns energy and treats fatty liver.

Bottom line: choose the right drug based on your goals.

#Semaglutide #Tirzepatide #Retatrutide #obesity #weightloss #glp1 #gip

https://threadreaderapp.com/thread/2073392304090390683.html

Weight Loss Drug Update

Semaglutide - GLP1 = 15% weight loss
Tirzepatide - GLP1 + GIP = 21-25% WL
Retatrutide - GLP1 + GIP + Glucagon = 28% WL

Orforglipron (oral!) - non-peptide GLP1 = 12% WL
CagriSema - amylin combo = 23% WL

Survodutide treats fatty liver (62% improved MASH)

#Glucagon drugs (like Ret) burns energy and treats fatty liver.

Bottom line: choose the right drug based on your goals.

#Semaglutide #Tirzepatide #Retatrutide #obesity #weightloss #glp1 #gip

https://threadreaderapp.com/thread/2073392304090390683.html

Weight Loss Drug Update

Semaglutide - GLP1 = 15% weight loss
Tirzepatide - GLP1 + GIP = 21-25% WL
Retatrutide - GLP1 + GIP + Glucagon = 28% WL

Orforglipron (oral!) - non-peptide GLP1 = 12% WL
CagriSema - amylin combo = 23% WL

Survodutide treats fatty liver (62% improved MASH)

#Glucagon drugs (like Ret) burns energy and treats fatty liver.

Bottom line: choose the right drug based on your goals.

#Semaglutide #Tirzepatide #Retatrutide #obesity #weightloss #glp1 #gip

https://threadreaderapp.com/thread/2073392304090390683.html

Weight Loss Drug Update

Semaglutide - GLP1 = 15% weight loss
Tirzepatide - GLP1 + GIP = 21-25% WL
Retatrutide - GLP1 + GIP + Glucagon = 28% WL

Orforglipron (oral!) - non-peptide GLP1 = 12% WL
CagriSema - amylin combo = 23% WL

Survodutide treats fatty liver (62% improved MASH)

#Glucagon drugs (like Ret) burns energy and treats fatty liver.

Bottom line: choose the right drug based on your goals.

#Semaglutide #Tirzepatide #Retatrutide #obesity #weightloss #glp1 #gip

https://threadreaderapp.com/thread/2073392304090390683.html

Weight Loss Drug Update

Semaglutide - GLP1 = 15% weight loss
Tirzepatide - GLP1 + GIP = 21-25% WL
Retatrutide - GLP1 + GIP + Glucagon = 28% WL

Orforglipron (oral!) - non-peptide GLP1 = 12% WL
CagriSema - amylin combo = 23% WL

Survodutide treats fatty liver (62% improved MASH)

#Glucagon drugs (like Ret) burns energy and treats fatty liver.

Bottom line: choose the right drug based on your goals.

#Semaglutide #Tirzepatide #Retatrutide #obesity #weightloss #glp1 #gip

https://threadreaderapp.com/thread/2073392304090390683.html

Weight Loss Drug Update

Semaglutide - GLP1 = 15% weight loss
Tirzepatide - GLP1 + GIP = 21-25% WL
Retatrutide - GLP1 + GIP + Glucagon = 28% WL

Orforglipron (oral!) - non-peptide GLP1 = 12% WL
CagriSema - amylin combo = 23% WL

Survodutide treats fatty liver (62% improved MASH)

#Glucagon drugs (like Ret) burns energy and treats fatty liver.

Bottom line: choose the right drug based on your goals.

#Semaglutide #Tirzepatide #Retatrutide #obesity #weightloss #glp1 #gip

https://threadreaderapp.com/thread/2073392304090390683.html

Weight Loss Drug Update

Semaglutide - GLP1 = 15% weight loss
Tirzepatide - GLP1 + GIP = 21-25% WL
Retatrutide - GLP1 + GIP + Glucagon = 28% WL

Orforglipron (oral!) - non-peptide GLP1 = 12% WL
CagriSema - amylin combo = 23% WL

Survodutide treats fatty liver (62% improved MASH)

#Glucagon drugs (like Ret) burns energy and treats fatty liver.

Bottom line: choose the right drug based on your goals.

#Semaglutide #Tirzepatide #Retatrutide #obesity #weightloss #glp1 #gip

https://threadreaderapp.com/thread/2073392304090390683.html

https://www.europesays.com/uk/1090003/ Semaglutide dose may matter more than weight loss for heart health #Blood #BloodPressure #Cardiometabolic #CardiovascularDisease #Glucagon #GlucagonLikePeptide1 #Glucose #Health #heart #mortality #Obesity #Receptor #Semaglutide #UK #UnitedKingdom #WeightLoss

https://www.europesays.com/ie/584916/ Semaglutide dose may matter more than weight loss for heart health #blood #BloodPressure #Cardiometabolic #CardiovascularDisease #Éire #Glucagon #GlucagonLikePeptide1 #Glucose #Health #Heart #IE #Ireland #Mortality #Obesity #Receptor #semaglutide #WeightLoss

Nearly one in 10 Britons use or want weight-loss medication

A nationally representative survey estimates that millions of adults in Great Britain have already used GLP-1-based weight-loss medicines…
#NewsBeep #News #Health #Agonist #AU #Australia #Chronic #diabetes #Efficacy #Glucagon #Glucagon-likePeptide-1 #Glucose #Healthcare #medicine #Obesity #Receptor #type2diabetes #WeightLoss #weightmanagement
https://www.newsbeep.com/au/797346/

Nearly one in 10 Britons use or want weight-loss medication

A nationally representative survey estimates that millions of adults in Great Britain have already used GLP-1-based weight-loss medicines…
#NewsBeep #News #Health #Agonist #AU #Australia #Chronic #diabetes #Efficacy #Glucagon #Glucagon-likePeptide-1 #Glucose #Healthcare #medicine #Obesity #Receptor #type2diabetes #WeightLoss #weightmanagement
https://www.newsbeep.com/au/797346/

https://www.europesays.com/ie/582786/ Gut microbiota may shape eating behavior and guide new obesity treatments #appetite #Bacterial #blood #Brain #diet #Dysbiosis #EatingDisorder #Éire #food #Ghrelin #Glucagon #GlucagonLikePeptide1 #GutBrainAxis #IE #inflammation #Ireland #Leptin #MealTiming #Metabolites #Obesity #Pharmacology #prebiotics #Probiotics #Stress #Technology

GLP-1RAs linked to lower risk of amputation in diabetes with PAD

The largest meta-analysis to date suggests GLP-1RAs may reduce major limb complications in people wi…
#NewsBeep #News #Health #Amputation #AU #Australia #Blood #BloodVessels #CardiovascularDisease #diabetes #Glucagon #Glucagon-likePeptide-1 #Glucose #mortality #MyocardialInfarction #Peripheralarterydisease #ProgenitorCells #Receptor #semaglutide #Stroke #therapy #type2diabetes #Vascular #walking
https://www.newsbeep.com/au/791389/

GLP-1RAs linked to lower risk of amputation in diabetes with PAD

The largest meta-analysis to date suggests GLP-1RAs may reduce major limb complications in people wi…
#NewsBeep #News #Health #Amputation #AU #Australia #Blood #BloodVessels #CardiovascularDisease #diabetes #Glucagon #Glucagon-likePeptide-1 #Glucose #mortality #MyocardialInfarction #Peripheralarterydisease #ProgenitorCells #Receptor #semaglutide #Stroke #therapy #type2diabetes #Vascular #walking
https://www.newsbeep.com/au/791389/

GLP-1 medications may improve long-term health for people with peripheral artery disease https://www.byteseu.com/2156474/ #Agonist #amputations #Blood #BloodSugar #BloodVessel #cardiology #Chronic #ct #diabetes #GLP1 #Glucagon #GlucagonLikePeptide1 #Health #Heart #HeartAttack #Inflammation #InterventionalCardiology #Kidney #Medicine #metformin #Obesity #PeripheralArteryDisease #Receptor #Research #stroke #Type2Diabetes #WeightLoss

https://www.europesays.com/ch/83460/ Pfizer, Amgen and Roche race to cut GLP-1 obesity shots to 4–13 a year #amylin #GLP1 #glucagon #mounjaro #ObesityDrug #ObesityTreatment #Roche #Wegovy #글루카곤 #마운자로 #비만약 #비만치료제 #아밀린 #위고비

https://www.europesays.com/ie/527489/ GLP-1 medicines may cut clot-related risks in chronically inflamed patients #Agonist #Aids #AutoimmuneDisease #Éire #Glucagon #GlucagonLikePeptide1 #Health #Heart #IE #Ireland #Mortality #Obesity #PublicHealth #Receptor #Stroke #therapy

GLP-1 users say the drugs quiet food noise but do not replace lifestyle change

Interviews with patients across 15 US states revea…
#dining #cooking #diet #food #Food #cardiovasculardisease #chronic #Diabetes #drugs #Efficacy #Glucagon #glucagonlikepeptide1 #Healthcare #metabolism #nausea #obesity #receptor #Research #sleep #stomach #type2diabetes #weightloss #WeightManagement
https://www.diningandcooking.com/2676729/glp-1-users-say-the-drugs-quiet-food-noise-but-do-not-replace-lifestyle-change/

GLP-1 users say the drugs quiet food noise but do not replace lifestyle change

Interviews with patients across 15 US states revea…
#dining #cooking #diet #food #Food #cardiovasculardisease #chronic #Diabetes #drugs #Efficacy #Glucagon #glucagonlikepeptide1 #Healthcare #metabolism #nausea #obesity #receptor #Research #sleep #stomach #type2diabetes #weightloss #WeightManagement
https://www.diningandcooking.com/2676729/glp-1-users-say-the-drugs-quiet-food-noise-but-do-not-replace-lifestyle-change/

GLP-1 users say the drugs quiet food noise but do not replace lifestyle change

Interviews with patients across 15 US states revea…
#dining #cooking #diet #food #Food #cardiovasculardisease #chronic #Diabetes #drugs #Efficacy #Glucagon #glucagonlikepeptide1 #Healthcare #metabolism #nausea #obesity #receptor #Research #sleep #stomach #type2diabetes #weightloss #WeightManagement
https://www.diningandcooking.com/2676729/glp-1-users-say-the-drugs-quiet-food-noise-but-do-not-replace-lifestyle-change/

GLP-1 users say the drugs quiet food noise but do not replace lifestyle change https://www.diningandcooking.com/2676729/glp-1-users-say-the-drugs-quiet-food-noise-but-do-not-replace-lifestyle-change/ #CardiovascularDisease #chronic #Diabetes #diet #drugs #Efficacy #food #Glucagon #GlucagonLikePeptide1 #Healthcare #metabolism #nausea #obesity #receptor #Research #sleep #stomach #Type2Diabetes #WeightLoss #WeightManagement

GLP-1 users say the drugs quiet food noise but do not replace lifestyle change https://www.diningandcooking.com/2676729/glp-1-users-say-the-drugs-quiet-food-noise-but-do-not-replace-lifestyle-change/ #CardiovascularDisease #chronic #Diabetes #diet #drugs #Efficacy #food #Glucagon #GlucagonLikePeptide1 #Healthcare #metabolism #nausea #obesity #receptor #Research #sleep #stomach #Type2Diabetes #WeightLoss #WeightManagement

https://www.europesays.com/ie/512609/ Justicia carnea extract alleviates oxidative stress in pancreatitis #AntiInflammatory #Antioxidant #Chronic #Éire #Ethanol #Glucagon #Health #IE #InflammatoryDisease #Ireland #Lipase #MouseModel #OxidativeStress #pancreatitis #Pharmacology #Research #Stress

https://www.europesays.com/ie/473866/ People judge GLP-1 users more harshly than dieters #Agonist #diet #Drugs #Éire #Exercise #Glucagon #GlucagonLikePeptide1 #Health #Healthcare #IE #Ireland #Medication #MentalHealth #Obesity #Receptor #Research #semaglutide #Traction #WeightLoss

People judge weight loss more harshly when GLP-1 drugs are involved, study finds

Even when medication is paired with diet and exercise, people may still feel their weight loss is less…
#NewsBeep #News #Health #Diet #Drugs #exercise #GB #Glucagon #Glucagon-likePeptide-1 #Obesity #Receptor #research #UK #UnitedKingdom #WeightLoss
https://www.newsbeep.com/uk/547637/

https://www.europesays.com/uk/914586/ People judge weight loss more harshly when GLP-1 drugs are involved, study finds #diet #Drugs #exercise #Glucagon #GlucagonLikePeptide1 #Health #Medication #Obesity #Receptor #Research #UK #UnitedKingdom #WeightLoss

https://www.europesays.com/ie/450964/ People judge weight loss more harshly when GLP-1 drugs are involved, study finds #diet #Drugs #Éire #Exercise #Glucagon #GlucagonLikePeptide1 #Health #IE #Ireland #Obesity #Receptor #Research #WeightLoss

https://www.europesays.com/ie/389218/ Patients who stop GLP-1 drugs often restart or try alternatives #diabetes #DiabetesMellitus #Drugs #Éire #FattyLiver #Glucagon #GlucagonLikePeptide1 #Glucose #Health #Healthcare #IE #Ireland #Liver #Metabolism #Obesity #ObstructiveSleepApnea #Receptor #semaglutide #Sleep #SleepApnea #Type2Diabetes #WeightLoss

https://www.europesays.com/ie/375258/ Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit #Addiction #Alcohol #Brain #Cannabis #diabetes #Drugs #Éire #Glucagon #GlucagonLikePeptide1 #Glucose #Health #Healthcare #IE #Ireland #Mortality #Nicotine #Overdose #pharmacy #Preclinical #Receptor #Research #Type2Diabetes

https://www.europesays.com/ie/372251/ Engineered lettuce may turn injectable GLP-1 therapies into oral pills #appetite #Biotechnology #blood #BloodSugar #Chloroplasts #diabetes #Drugs #Éire #Exenatide #Fasting #Genome #Glucagon #GlucagonLikePeptide1 #Health #Hormone #IE #Insulin #Ireland #Manufacturing #medicine #Obesity #oral #peptides #Receptor #Research #Stomach #Type2Diabetes #WeightManagement

https://www.europesays.com/ie/354769/ Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity #Agonist #Drugs #Efficacy #Éire #Glucagon #GlucagonLikePeptide1 #HbA1c #Hormone #IE #Ireland #Obesity #Placebo #Receptor #Technology #WeightLoss

https://www.europesays.com/ie/335256/ Users prioritize weight loss despite side effects #Agonist #BariatricSurgery #blood #cancer #CardiovascularDisease #Chronic #Constipation #diabetes #Drugs #Efficacy #Éire #Glucagon #GlucagonLikePeptide1 #Glucose #Health #IE #Internet #Ireland #MetabolicDisease #Mortality #Nausea #Obesity #PhysicalActivity #Receptor #Research #semaglutide #Surgery #Type2Diabetes #Vomiting #WeightLoss #WeightManagement

Improving survival in people with severe psychiatric disorders

An exper…
#NewsBeep #News #Health #Agonist #AU #Australia #bipolardisorder #Cardiometabolic #CardiovascularDisease #Chronic #ChronicKidneyDisease #depressivedisorder #diabetes #disability #Drugs #Exenatide #food #Glucagon #Glucagon-likePeptide-1 #Kidney #KidneyDisease #Lithium #majordepressivedisorder #metabolicdisease #mortality #Obesity #oral #Receptor #Renaldisease #Schizophrenia #type2diabetes
https://www.newsbeep.com/au/437881/

https://www.europesays.com/ie/303898/ Improving survival in people with severe psychiatric disorders #Agonist #BipolarDisorder #Cardiometabolic #CardiovascularDisease #Chronic #ChronicKidneyDisease #DepressiveDisorder #diabetes #Disability #Drugs #Éire #Exenatide #food #Glucagon #GlucagonLikePeptide1 #Health #IE #Ireland #Kidney #KidneyDisease #lithium #MajorDepressiveDisorder #MetabolicDisease #Mortality #Obesity #oral #Receptor #RenalDisease #Schizophrenia #Type2Diabetes

https://www.europesays.com/ie/214425/ Diabetes drugs linked to slower frailty progression in older adults #Aging #blood #BloodSugar #diabetes #Disability #Drugs #Éire #fatigue #Glucagon #GlucagonLikePeptide1 #Glucose #Health #Heart #IE #Ireland #Receptor #Research #semaglutide #Type2Diabetes

https://www.europesays.com/ie/211267/ WHO releases first guideline on the use of GLP-1 therapies for treating obesity #Chronic #ChronicDisease #diabetes #Efficacy #Éire #GlobalHealth #Glucagon #GlucagonLikePeptide1 #Health #IE #Ireland #Obesity #PhysicalActivity #Type2Diabetes

https://www.europesays.com/ie/201497/ Regenerative medicine offers a pathway toward curing type 1 diabetes #Autoimmunity #Cell #diabetes #Éire #Endocrine #Glucagon #Health #IE #Immunosuppression #Insulin #Ireland #medicine #ProgenitorCells #Proliferation #Research #StemCells #therapy #Type1Diabetes

https://www.europesays.com/ie/186314/ Tirzepatide may only temporarily suppress brain activity involved in “food noise” #Agonist #BingeEatingDisorder #Brain #BrainSurgery #CT #diabetes #Drugs #EatingDisorder #Éire #food #Frequency #Glucagon #GlucagonLikePeptide1 #Glucose #Health #hospital #Hypothalamus #IE #Ireland #medicine #Neurosurgery #Obesity #Receptor #Research #Surgery #therapy #Type2Diabetes #WeightLoss